14-3-3 proteins—a moonlight protein complex with therapeutic potential in neurological disorder: in-depth review with Alzheimer’s disease
Alzheimer’s disease (AD) affects millions of people worldwide and is a gradually worsening neurodegenerative condition. The accumulation of abnormal proteins, such as tau and beta-amyloid, in the brain is a hallmark of AD pathology. 14-3-3 proteins have been implicated in AD pathology in several way...
Main Authors: | Gholamareza Abdi, Mukul Jain, Nil Patil, Bindiya Upadhyay, Nigam Vyas, Manish Dwivedi, Radhey Shyam Kaushal |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2024.1286536/full |
Similar Items
-
Structural insights into the functional roles of 14-3-3 proteins
by: Veronika Obsilova, et al.
Published: (2022-09-01) -
14-3-3 proteins in guard cell signaling
by: Valérie eCotelle, et al.
Published: (2016-01-01) -
The yeast 14-3-3 proteins Bmh1 and Bmh2 regulate key signaling pathways
by: Veronika Obsilova, et al.
Published: (2024-01-01) -
Neuronal Excitation Induces Tau Protein Dephosphorylation via Protein Phosphatase 1 Activation to Promote Its Binding with Stable Microtubules
by: Sosuke Yagishita, et al.
Published: (2024-06-01) -
Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease
by: Hua Zhang, et al.
Published: (2018-09-01)